Company

Proof Diagnostics, Inc.

Proof Diagnostics developed portable CRISPR-based testing tools for detecting infectious diseases.

About

Proof Diagnostics developed diagnostic tools, including a portable CRISPR-based system for detecting infectious diseases. Founded in 2020 and based in Cambridge, US, it was acquired by Ginkgo BioWorks, Inc. in February 2024 from ARCH Venture Partners, F-Prime Capital, and Madrona Venture Group.

1Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in